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ABSTRACT 
Cardiovascular disease (CVD) related to HIV infection is becoming a major public health 
concern in the United States. Epidemiologic studies show that prolonged use of Highly 
Active Antiretroviral Therapy, HIV/AIDS itself, and a combination of traditional vascular 
risk factors increase the risk for CVD among people with HIV/AIDS. However, little is 
known about any racial disparities in the risk for CVD in the HIV/AIDS population. We 
conducted a systematic review and meta-analysis of the literature on HIV/AIDS and CVD 
(June 1, 2010-July 31, 2014) through MEDLINE to examine whether and how HIV-positive 
African Americans are disproportionately affected by CVD compared to their white 
counterparts. The corrected pooled effect from the eligible studies was 1.26 (95% confidence 
interval 1.22-1.30). Blacks living with HIV/AIDS have a higher risk for CVD than non-
Hispanic whites. The findings of this study provide an important basis for prevention efforts 
as well as recommendations for addressing the existing racial disparities in the risk for CVD 
among people living with HIV/AIDS. 
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INTRODUCTION 
 Societal concern about HIV/AIDS seems to be waning as public health professionals and 
researchers turn their focus on diseases such as heart disease and cancer that are considered to be 
the leading causes of death in the United States (CDC, 2016a). It is therefore not surprising that 
while there is a projected increase in National Institutes of Health (NIH) funding for research in 
other major diseases for the 2016 and 2017 fiscal years, there is no projected increase in funding 
for HIV/AIDS research (NIH, 2016). This shift in the public attitude can be mainly attributed to 
the successes of highly active antiretroviral therapy (HAART). The efficacy of HAART has 
resulted in prolonged survival among HIV-infected people, thus making AIDS a chronic disease 
instead of one of the leading causes of death that it was at the height of the AIDS epidemic in the 
1980s and 1990s (CDC, 1991). However, these successes have led to new sets of HIV-associated 
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complications, resulting in AIDS-related life-threatening chronic illnesses such as cardiovascular 
disease (Deeks, 2013). Epidemiological literature has shown a strong link between HIV/AIDS 
and cardiovascular disease (CVD) - whether due to long-term exposure to HIV, long-term 
exposure to antiretroviral therapy, or to traditional CVD risk factors (Barbaro, 2013; 
Muhammad, 2013; Oramasionwu, et al., 2012; Guaraldi, et al., 2011; Heffernan, et al., 2013; 
Kaplan et al., 2008; Islam, et al., 2012; Bavinger, et al., 2013). Taken together, this 
epidemiological evidence suggests that people living with HIV/AIDS (PLWHA) are at increased 
risk for CVD compared to the uninfected population.  
CVD is the leading cause of death among blacks in the United States (CDC, 2016b). 
Furthermore, even though African Americans represent only around 13% of the U.S. population, 
they account for about 44% of new HIV infections and a disproportionate share of PLWHA and 
AIDS-related deaths (CDC, 2015). While several studies have examined disparities in 
HIV/AIDS and CVD independently among African Americans, little is known about any racial 
differences in the risk for CVD among PLWHA. The few studies that have examined this 
question have produced contradictory results (Gebo et al., 2005; Triant et al., 2007; Gardner et 
al., 2003; Richter et al., 2005; Silverberg, et al., 2009; Oramasionwu et al., 2012). For instance, 
Gebo et al. (2005) investigated racial difference in CVD-related hospitalizations among people 
with HIV/AIDS in 12 states and concluded that blacks were at more increased risk for 
cerebrovascular-related hospitalizations compared to whites. However, the authors found that 
blacks were at a decreased risk for ischemic heart disease-related hospitalizations than their 
white counterparts. Triant et al. (2007) investigated the risk for myocardial infarction (AMI) 
among people with HIV/AIDS who had sought hospitalization. This study concluded that blacks 
had a higher rate of AMI compared to whites. Like the first two studies, Gardner et al. (2003) 
also focused on hospitalizations and assessed the risk for CVD-related hospitalization among 
people with HIV/AIDS. The authors concluded that there were no CVD-related black-white 
disparities among HIV/AIDS patients. The Richter et al. (2005) study examined HIV patients 
receiving outpatient care while the Silverberg et al. (2009) study evaluated racial differences in 
antiretroviral therapy adherence and CVD-related mortality. Both studies concluded that there 
were no differences between blacks and whites. The high prevalence of HIV/AIDS and CVD 
among blacks and the strong association between these two epidemics raises the question of 
whether the confluence of these two diseases creates a double-jeopardy for blacks and increases 
any existing racial health disparities. Through a systematic review and meta-analysis of the 
literature on HIV/AIDS and CVD, this study examines whether and how blacks who have 
HIV/AIDS experience increased risk for CVD relative to their white counterparts. Considering 
the well-established racial disparity in CVD morbidity and mortality, a failure to examine racial 
inequalities in the risk for CVD among PLWHA undermines efforts to truly understand, address, 
or stem the tide of HIV/AIDS and CVD.  
The present study makes a significant contribution to the literature on the intersection 
between HIV/AIDS, CVD, and race in the United States by expanding an earlier review done by 
Oramasionwu et al. (2012). Based on our comprehensive and systematic review of the literature 
on this topic, the study by Oramasionwu et al. (2012) is the only existing systematic literature 
review on racial disparities in relation to the risk for CVD among people living with HIV/AIDS. 
In the review, Oramasionwu and her team searched the electronic MEDLINE database for 
studies done between January 1, 1950 and May 31, 2010 to identify relevant articles. Of the 
original 43 studies they identified, the researchers ended up with 5, after excluding 38 studies 
that did not meet their inclusion criteria. Two of the studies the authors included in the final 
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systematic review concluded that blacks with HIV/AIDS had a higher risk for CVD than whites, 
while the remaining three studies did not find any significant racial difference in the risk for 
CVD. Acknowledging that their finding was inconclusive, Oramasionwu et al. (2012) point out 
the limitations in the time periods of the studies they reviewed, emphasize the need for “further 
research in this area” and underscore “the need for up-to-date data” on this topic. In addition, the 
authors call on future investigations to “differentiate between the different forms of CVD.” This 
is particularly critical in light of the possibility that blacks with HIV/AIDS are at increased risk 
for some forms of CVDs while, at the same time, at a decreased risk for others.  Our study takes 
up these challenges and seeks to fill the research gap identified by Oramasionwu at al. (2012). In 
addition, our study also overcomes two other limitations in the earlier review.  
First, some of the studies that Oramasionwu et al. (2012) included in their review 
examined racial differences in the risk for hospitalization for CVD, instead of the risk for 
incident CVD. In so doing, the review by Oramasionwu and her team included studies with 
different outcome variables – some having the risk for hospitalization as the outcome variable 
while others having the risk for contracting CVD as the outcome variable. Our review focuses on 
studies that examined the risk for CVD as the outcome variable. Second, by Oramasionwu’s own 
admission, their study was inconclusive. This suggests that the question of whether there are 
black-white disparities in the risk for CVD among people with HIV/AIDS has not been answered 
definitively. This is what our study attempts to do.  
 
METHODS 
Search Strategy 
We conducted a systematic search of the electronic MEDLINE database for studies 
published between June 1, 2010 and July 31, 2014. The search was limited to articles published 
in the English language that evaluated CVD among patients with HIV/AIDS. The primary 
outcome for our analysis was the incidence of CVD. As with the earlier review by Oramasionwu 
et al. (2012), the current study adapted the definition of CVD from the American Heart 
Association (AHA). Based on this definition, our search terms for CVD included “angina”, 
“atherosclerosis”, “atrial fibrillation”, “carotid artery”, “cerebrovascular disorders”, “coronary 
artery disease”, “coronary heart disease”, “heart failure”, “hypertension”, “ischemic heart 
disease”, “myocardial infarction”, “peripheral artery disease”, and “stroke”. These search terms 
also correspond to what existing literature identifies as additional biomarkers for CVD.  In 
addition to the CVD-related search terms, our search strategy also included terms associated with 
race/ethnicity such as “race”, “ethnicity”, “black”, and “African-American”, and search terms 
associated with HIV/AIDS such as “Human Immunodeficiency Virus”, “Acquired Immune 
Deficiency Syndrome”, “HIV”, and “AIDS.”  
Selection of studies 
Two researchers in our team independently screened the abstracts of all articles that were 
identified as relevant from the search strategy described above. Any disagreement between the 
two reviewers was resolved by consulting with the third reviewer. Studies were included if at 
least two reviewers agreed on their relevance, based on our pre-determined inclusion criteria. In 
addition, we hand-screened references of selected articles for additional relevant studies, using 
the same method described above. Similar to the inclusion criteria used by Oramasionwu and her 
team, we included any published journal articles if the studies: i) involved patients infected with 
HIV/AIDS, ii) evaluated CVD, iii) described original research data, iv) included only U.S. 
populations, v) compared black and white patients, and vi) involved non-pediatric populations. 
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To facilitate the meta-analysis, we also required that the studies to be included report a summary 
measure such as the odds ratio. Studies that failed to incorporate all seven of the above criteria 
were excluded. The selection process is presented in Figure 1. 
Data extraction 
Data was extracted by two researchers using a standardized form. The following 
information was extracted from each study: author, year of study, study design, study setting, 
sample size, racial distribution of sample, target population, CVD definition, effect size measure, 
and how blacks and whites compared on the outcome measure. Table 1 presents details of the 
studies included in the systematic review. 
Statistical Synthesis and Analysis  
We used Review Manager (RevMan, version 5.3 for Windows) to generate the results 
that have been used in this analysis and Stata to perform meta-regression. The Odds Ratio (OR) 
with 95% confidence intervals (CIs) was used as the primary outcome measure. We analyzed the 
outcome variable with both fixed- and random-effects models to see if there was a difference. 
Results were similar for the two models. We present the pooled study effects only for the fixed 
model based on the conventional wisdom that if the two models yield similar pooled estimates 
then the fixed-effect model is preferred because the fixed-effect is usually more precise than the 
random- effects model (Ryan, 2013). We assessed heterogeneity of the effect across the studies 
by using the I-squared (I2) statistic. The I2 value provides an estimate of the amount of variance 
across studies resulting from heterogeneity rather than chance (Ageno et al., 2008). Forest plots 
were generated for each of the individual effect estimates of the studies examined. 
We assessed publication bias using a funnel plot, while sensitivity analysis was done 
through the sequential exclusion of studies that appeared as outliers, followed by an assessment 
of statistical heterogeneity after each exclusion. A two-tailed p-value of 0.05 or less was 
considered statistically significant in assessing the overall effect of the outcome variable. We 
conducted secondary analysis through subgroup analysis and meta-regression. In general, this 
review confirms to the Preferred Reporting Items for Systematic Reviews and Meta-analysis 
(PRISMA) and with the Cochrane handbook on systematic reviews.  
 
125 Risk for Cardiovascular Disease in Blacks with HIV/AIDS 
Odhiambo et al. 
Journal of Health Disparities Research and Practice Volume 10, Issue 2 Spring 2017 
 http://digitalscholarship.unlv.edu/jhdrp/ 
 
126 Risk for Cardiovascular Disease in Blacks with HIV/AIDS 
Odhiambo et al. 
Journal of Health Disparities Research and Practice Volume 10, Issue 2 Spring 2017 
 http://digitalscholarship.unlv.edu/jhdrp/ 
       Table 1. Characteristics of Initial Studies Included in the Systematic Review 
Study/Year Study design Study Setting N Target 
Population 
CVD 
definition 
Relative 
Risk of 
CVD in 
Blacks vs 
Whites 
Armah et al., 
2012 
Observational, 
prospective 
longitudinal  
Veterans Aging 
Cohort Study 
(VACS) 
N=2368 
B 
(68.4%) 
W (19.7%) 
H (8.1%) 
O (3.8%) 
HIV 
infected and 
uninfected 
people 
D-dimer B>W 
 
Borges et al., 
2014 
Cross sectional  Participants in 
three 
randomized 
controlled 
trials: 
*SMART, 
†ESPRIT, and 
‡SILCAAT 
N=21,264 
 
HIV 
infected 
individuals  
under 
Active Anti-
retroviral 
Therapy 
D-dimer B>W 
Buchacz et al., 
2012 
Prospective 
Longitudinal 
observation 
HIV outpatient 
study data  
N=3,166 
B (31.5) 
W (56.6) 
H 
(11.9%) 
HIV 
infected 
adults 
(age 18 
and over) 
Hypertension B>W 
 
Dawood, 2014 Retrospective 
Cross 
sectional  
Data from 
SMART trial  
 N= 1,444 
B 
(37.6%) 
W (46.5%) 
O (16%) 
HIV 
infected and 
SMART 
participants 
Unspecified 
CVD 
B>W  
Factor, 2013 Prospective 
Longitudinal  
Participants in 
the  Natural 
History of 
Menopause in 
HIV-infected 
Drug Users of 
the Cohort of 
HIV at risk 
Aging Men’s 
Prospective 
Study 
N=659 
B (49%) 
W (13%) 
H (32%) 
O (6%) 
Peri-
menopausal 
women and 
older man 
with or at 
risk of HIV 
infection 
Hypertension B>W 
Friedberg et 
al., 2013 
Prospective 
longitudinal  
The veterans 
Aging Cohort 
Study Virtual 
Cohort 
N= 82459 
B (48%) 
W (37.8%) 
H 
(14.2%) 
HIV 
infected and 
uninfected 
persons 
Acute 
Myocardia
l Infarction 
B<W 
                                                          
* Strategies for Management of Antiretroviral Therapy 
† Evaluation of Subcutaneous Proleukin in a Randomized International Trial 
‡ Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts under Active 
Antiretroviral Therapy 
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Hsu et al., 
2013 
Prospective 
longitudinal  
Veterans 
Affairs HIV 
Clinical case 
registry from 
1996-2011 
N=30,533 
  B (54.1%) 
W (44.6%) 
O (1.3%) 
HIV 
infected 
persons 
Atrial 
Fibrillation 
 
B<W 
Krauskopf et 
al., 2013 
Prospective 
longitudinal  
Longitudinal 
study of the 
Ocular 
Complications 
of AIDS 
N=2,390 
B (37%) 
W (45%) 
O (18%) 
HIV 
infection 
and age 
from 13-
60 
Hypertension B>W 
Lichtenstein 
et al., 2010 
Longitudinal  Ten HIV 
clinics that 
participated in 
the HIV 
Outpatient 
Study (HOPS) 
after 2002 
N=2005 
W (52%) 
B (33%) 
O 
(12.3%) 
HIV,  
patients, 
and CVD 
Unspecified 
CVD 
B=W 
Medina-Torne 
et al., 2012 
Cross 
sectional  
Medical care at 
the Naval 
Medical Center 
San Diego 
(NMCSD) or 
the National 
Naval Medical 
Center 
(NNMC) in 
Bethesda, MD. 
N= 707 
B 
(37.5%) 
W (48.9%) 
O 
(13.6%) 
 
HIV & 
HAART 
Hypertension B=W 
 
Monroe, 2012 Cross 
sectional  
Multicenter 
AIDS Cohort 
Study (MACS) 
N=856 
 
HIV/AID
S infected 
men 
Unspecified 
CVD 
B=W 
Parrinello et 
al., 2012 
Longitudinal Women’s 
Interagency 
HIV Study 
(WIHS) 
N= 691 
B (64%) 
W/O 
(9%) 
H (27%) 
HIV 
infected 
women 
Carotid 
Artery 
B=W 
Tripathi et al., 
2014 
Prospective 
Longitudinal  
South Carolina 
Medicaid 
system and 
HIV/AIDS 
reporting 
system 
N= 13,632 
B (70.7) 
W (20.9) 
O (8.4%) 
HIV 
infected 
and 
diabetes 
Diabetes 
Mellitus 
B>W 
 
Abbreviations: W=Whites, B=Blacks, H=Hispanics, A=Asians, O=Others 
 
RESULTS 
 Our combined search strategy yielded 111 studies (Figure 1). Of these, 25 studies were 
excluded after scanning the abstracts for relevance. Another 73 were excluded after a full-text 
review because they did not meet our inclusion criteria. The remaining 13 studies included 
information that was relevant for the systematic review. We found it necessary to disaggregate 
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data from three studies for purposes of the meta-analysis. The first two studies were those by 
Buchacz et al. (2012) and Factor et al. (2013). These studies included male and female 
respondents and reported the findings separately by gender. Since, in some cases, the outcome 
variables in these studies differed by gender, aggregating the outcome variables would have 
masked these gender differences. Each of these studies were therefore entered in the analysis 
twice – the first time using the statistics generated for females and the second time using 
statistics for males. The third study was by Parrinello et al. (2012). This study was based on a 
female sample but the sample was divided into three groups that varied by HIV treatment and 
viremia status. The first group was of women who were treated and aviremic. The second group 
was of women who were treated and viremic. The third group was of women who were not 
treated. Since the results for these three groups were different, we decided to consider the groups 
separately in the meta-analysis. In all, the disaggregation of these three studies resulted in a total 
of 17 articles, as shown in Table 2. 
 
    Table 2. Characteristics of Final Studies Included in the Meta-Analysis 
Study/Year Study 
Design 
CVD 
definition 
Gender Mean 
Age 
Study 
size 
Study 
location 
Black vs 
White 
CVD 
Risk 
Armah et al., 
2012 
Longitudinal D-dimer Combined 
M&F 
51.8 N=2,368 
 
National B>W 
Borges et al., 
2014 
Cross sectional D-dimer Combined 
M&F 
43 N=21,26
4 
National B>W 
Buchacz et al., 
2012 (F) 
Longitudinal  Hypertension F 45 N=673 Regional 
(8 cities)  
B=W 
Buchacz et al., 
2012 (M) 
Longitudinal  Hypertension M 47 N=2,493 Regional 
(8 cities)  
B>W 
Dawood, 2014  Cross sectional Unspecified 
CVD 
Combined 
M&F 
44.1  N= 
1,444 
 
National 
 
B>W  
Factor et al., 
2013 (F) 
Longitudinal Hypertension F 43.4  N= 171 
 
Bronx, 
NY 
B>W 
Factor et al., 
2013 (M) 
Longitudinal Hypertension M 54.4  N= 213 
 
Bronx, 
NY 
B>W 
Friedberg et al., 
2013 
Longitudinal Acute 
Myocardial 
Infarction 
Combined 
M&F 
48.2 N=27,35
0  
 
National B<W 
Hsu et al., 2013 Longitudinal Atrial 
Fibrillation 
Combined 
M&F 
53.6 N=30,53
3 
Nationw
ide  
B<W 
Krauskopf et 
al., 2013 
Longitudinal Hypertension Combined 
M&F 
43 
 
N=2,390 
 
National 
 
B>W 
Lichtenstein et 
al., 2010  
Longitudinal Unspecified 
CVD 
Combined 
M&F 
42 N=2,005 
 
Regiona
l  
(6 
states) 
B=W 
Medina-Torne 
et al., 2012  
Cross sectional Hypertension Combined 
M&F 
41 N= 707 
 
San 
Diego, 
CA  
& 
B=W 
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Bethesda, 
MD 
Monroe, 2012  
 
Cross sectional Coronary 
Artery 
Calcification 
M 48.9 
 
N=856 
 
National B=W 
Parrinello et 
al., 2012-1 
Longitudinal Carotid 
Artery 
F 41.7 N=226 National B>W 
Parrinello et 
al., 2012-2 
Longitudinal Carotid 
Artery 
F 42.8 N=148 National B=W 
Parrinello et 
al., 2012-3 
Longitudinal Carotid 
Artery 
F 40.3 N=227 National B=W 
Tripathi et al., 
2014  
Longitudinal Diabetes 
Mellitus 
Combined 
M&F 
39 N= 13,632 
 
South 
Carolina 
B>W 
 
 
 
In all, 53% of the studies concluded that blacks living with HIV/AIDS had higher risks 
for CVD than their white counterparts. The remaining studies either reported that there was no 
racial difference in the black-white CVD risk (35%) or that whites had higher risks for CVD than 
blacks (12%). Thus, a majority of the studies examined concluded that blacks with HIV/AIDS 
had higher risks for CVD than their white counterparts. 
Figure 2 presents two forest plots for the primary and secondary analyses, respectively. In 
the primary analysis we estimated the pooled effect of all 17 articles that were included in the 
review. We calculated the Odds Ratio (OR) for the 17 articles to be 1.21 (95% CI 1.17-1.24, p < 
0.00001), suggesting that blacks living with HIV/AIDS had a 21% higher risk of CVD 
compared to their white counterparts. However, we detected substantial heterogeneity (I2 = 
89%; p < 0.00001), suggesting that not all of the studies included in the analysis evaluated the 
same effect and, thus, the calculation of the summary effect measure would be invalid. A visual 
inspection of the primary funnel plot (not included) showed that there were five outliers (Factor 
et al., 2013 (M); Friedberg et al., 2013; Hsu et al., 2013; Krauskopf et al., 2013; and Parrinello 
et al., 2012-2) suggesting that these five studies could be inconsistent with the rest of the studies 
in the analysis. We decided to perform a sensitivity analysis on the five studies. 
We examined the effect of excluding the studies, excluding one study at a time and 
assessing heterogeneity after each exclusion. The result of the sensitivity analysis (Table 3) 
showed that excluding the five studies reduced the overall heterogeneity (I2) from 89% 
(p<0.0001) to 34% (p=0.12). These results are also consistent with the forest plot generated 
after excluding the five studies as shown in the corrected model presented in the second half of 
Figure 2, thus justifying the exclusion of the five outliers. The low I2 suggests that there is no 
statistically significant heterogeneity in the corrected model, implying greater consistency 
across the remaining studies. The corrected OR of 1.26 (95% CI 1.22, 1.30) suggests that the 
risk for CVD was 26% higher among blacks with HIV/AIDS, compared to their white 
counterparts. The symmetrical funnel plot (Figure 3) suggests the absence of any significant 
heterogeneity in the corrected model.    
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______________________________________________________________________________ 
Figure 2: Forest Plot Comparing the Risk for CVD between Blacks and Whites Living with HIV/AIDS for 
the Primary and Sensitivity Analyses 
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We further explored potential heterogeneity by examining effect sizes in subgroups based 
on differences in types of cardiovascular disease, study design, study location, gender, age, and 
study size. None of the six variables in the subgroup analysis presented in Table 4 shows any 
statistically significant reduction in the I2 below the corrected I2 of 34% - an indication that the 
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pooled effect does not vary by any of the variables examined. We also ran a meta-regression 
using the six variables examined in the subgroup analysis. None of the variables showed any 
statistically significant effect on the outcome variable, confirming the finding of the subgroup 
analysis that there is no significant heterogeneity in the remaining studies included in this meta-
analysis. 
 
          Table 4: Subgroup Analysis for Studies included in the Secondary Analysis 
Variable No. of Studies in 
the Meta-Analysis 
OR 
(95% CI) 
I2 
Parameter 
P-Value 
CVD Definition 
   D-Dimer 
   Hypertension 
   Unspecified CVD 
   Carotid Artery 
   Other CVD 
12 
2 
4 
2 
2 
2 
 
1.27 (1.22-1.32) 
1.25 (1.17-1.33) 
1.36 (1.06-1.74) 
1.29 (0.96-1.72) 
1.28 (1.08-1.50) 
 
67 
23 
65 
67 
69 
 
0.08 
0.27 
0.09 
0.08 
0.07 
Study Design 
   Longitudinal Studies 
Cross-Sectional 
Studies 
12 
8 
4 
 
1.28 (1.16-1.41) 
1.25 (1.03-1.52) 
 
35 
48 
 
0.15 
0.12 
Study Location 
   National Studies 
   Regional Studies 
12 
6 
6 
 
1.27 (1.22-1.32) 
1.25 (1.18-1.33) 
 
56 
1 
 
0.04 
0.41 
Gender 
   M&F Studies 
   Female Studies 
   Male Studies 
12 
6 
4 
2 
 
1.27 (1.22-1.32) 
1.20 (1.05-1.37) 
1.26 (1.17-1.36) 
 
27 
51 
66 
 
0.23 
0.10 
0.08 
Age 
   35-45 Years 
   46-56 Years 
12 
9 
3 
 
1.26 (1.21-1.31) 
1.28 (1.19-1.38 
 
24 
65 
 
0.23 
0.06 
Study Size 
   Under 10K 
   Over 10K 
12 
10 
2 
 
1.26 (1.19-1.34) 
1.26 (1.21-1.31) 
 
45 
0 
 
0.06 
0.56 
 
DISCUSSION AND CONCLUSION 
This review provides a more comprehensive and updated assessment of the black-white 
differences in the risk for cardiovascular disease among people with HIV/AIDS in the United 
States. The last published review by Oramasionwu et al. (2012) found inconclusive evidence 
regarding the interaction between race, HIV/AIDS, and CVD. Our study examined this question 
by reviewing a larger and more recent sample of studies by not just conducting a systematic 
review, as  Oramasionwu and her team did, but, in addition, conducting a meta-analysis. This 
enabled us to bring together a number of separately conducted studies, sometimes with 
conflicting findings, and synthesizing, pooling them quantitatively, and re-analyzing their results 
to assess the combined effect of race on our outcome variable. Meta-analysis has been 
considered as one of the highest levels of evidence (Garg et al., 2016). The robustness of meta-
analysis comes from the fact that, by combining the samples of individual studies, the overall 
sample size is increased, thereby improving the statistical power of the analysis as well as the 
precision of the estimates of the outcome variable (Akobeng, 2005).   
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Our results suggest that blacks who are living with HIV/AIDS have a higher risk for 
CVD compared to whites in the same group. Specifically, our study found that blacks with 
HIV/AIDS had a 26% higher risk of CVD than their white counterparts. In this sense, our 
findings do not support the overall conclusion by Oramasionwu et al. (2012) that there is limited 
evidence regarding the interaction between race, HIV/AIDS, and CVD. A possible reason why 
our general finding is different from that of Oramasionwu et al. (2012) is their rather small 
sample size of only 5 studies and their failure to assess the pooled effect of race from the 
contradictory studies included in their review. In addition, given the periods when the studies in 
the Oramasionwu et al. (2012) review were conducted (1993-2005), and considering the 
increasing racial health disparities in the United States, it is possible that our findings reflect the 
changing landscape of CVD health disparities in the HIV/AIDS population. 
Two significant changes have occurred in the U.S. population between the period of the 
studies included in the Oramasionwu et al, (2012) review and ours. In the first place, there has 
been a marked change in the size of racial and ethnic minority groups in the U.S. population, 
resulting in a more diverse population and an increase in the percentage of the minority U.S. 
population (Colby & Ortman, 2015). Such a population shift underscores the importance of 
monitoring the health status and health behavior of these groups (Kurian & Carderelli, 2007). 
Secondly, racial disparities in cardiovascular disease have continued to increase in the United 
States since the Oramasionwu et al. (2012) review (American Heart Association, 2016) as have 
the prevalence of many of the risk factors associated with cardiovascular disease in the black 
population. The studies we have reviewed capture these more recent trends and, therefore, 
provide a more up-to-date assessment of the phenomenon. 
Racial disparities in health date back to some of the earliest health records in the United 
States and show that blacks have poorer health than whites across various health indicators 
(Williams & Sternthal, 2010). The dominant view of early research on racial health disparities 
was that the disparities reflected innate biological differences between the racial groups (Krieger, 
1987). However, in spite of attempts to address the biological forces that were seen as the causes 
of such disparities, racial inequalities in health have continued to persist (Williams, 1997; 
Lahelma & Rahkonen, 1997; Mitchell, 2015) or to widen (Orsi et al., 2010). The fact that health 
disparities still persist raises important questions about the origins of these disparities in the 
structural, cultural, and personal conditions of life (Schnittker & McLeod, 2005). Sociological 
contribution to the understanding of health disparities date back to the writings of scholars like 
W.E.B. Du Bois (Du Bois, 1967). A central argument in Du Bois’ explanation was that social 
factors, rather than inherent biological traits, caused racial health disparities. Other studies have 
echoed Du Bois by associating these disparities with increased poverty or socioeconomic 
inequality, disproportionate incarceration, fewer educational opportunities, adverse social 
environments, and residential segregation (LaVeist, 1989; Link & Phalen, 1995; Williams & 
Collins, 1995; Hayward et al., 2000; Lanier & Sutton, 2013).  
As Schnittcker & McLeod (2005) point out, the causes of health disparities are not just 
social or psychological but both social and psychological (emphasis added). Similarly, it can be 
argued that, contrary to the paradigmatic schism created by differing perspectives on racial 
health disparities, the causes of the disparities, such as those we found in the risk for CVD in 
people with HIV/AIDS, are not just biomedical or social. They are both biomedical and social. 
The confluence of HIV/AIDS and CVD highlights a need to examine a merged perspective that 
is broad-based, integrative, and provides a more comprehensive understanding of reasons for the 
racial health inequalities. In fact, as Dankwa-Mullan et al. (2010) aptly point out, the current 
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landscape of health disparities science (should) include(s) an understanding of the complex 
associations between biological and nonbiological determinants of health. These sentiments were 
also echoed by Williams et al. (2010) who argued that research on racial differences in health 
should seek to understand how social exposures, or determinants, combine with biology to affect 
the social distribution of disease. “Otherwise, we run the risk of creating false antitheses of 
mutually exclusive explanations where they do not apply” (Lahelma & Rahkonen, 1997). 
To understand the reasons why blacks living with HIV/AIDS experience higher risk for 
CVD relative to their white counterparts, it is important to consider two main factors. First, as 
has been well established in much of the health literature, blacks are disproportionately affected 
by CVD compared to non-Hispanic whites.  While this disparity has been attributed to a host of 
behavioral, social, economic, environmental, and structural factors (Ma & Ma, 2015; Golden et 
al,. 2015; American Heart Association, 2014; Sharma et al., 2004), there is also evidence that 
biological factors play an important determining role in African Americans’ differential 
vulnerability to CVD (Cooper, 2004; Gibbons, 2004; Schisler, et al., 2009). It is conceivable that 
when this genetic predisposing intersects with the risk factors for HIV/AIDS, the resultant effect 
is an increased risk for CVD among blacks, thus compounding the racial disparities observed. 
Population groups, like African Americans, with higher baseline risks for diseases such as CVD, 
are more likely to exhibit higher risks for HIV/AIDS coinfections (Kaufman, 2008). It is 
therefore conceivable that the disproportionate burden of HIV/AIDS among blacks increases 
their vulnerability to CVD.   
Second, studies examining the effect of HIV therapy on CVD risks have concluded that 
people who are exposed to certain antiretroviral therapies, particularly protease-inhibiter (PI)-
based regimens, tend to experience elevated risks for CVD due to side effects from the HIV 
medication and inflammatory effects of the virus (Lang, 2015). Is it possible that different 
antiretroviral therapies will work differently in different racial groups? Even though our study 
was not able to directly examine this question due to lack of adequate information from the 
studies we reviewed, several health studies have answered this question affirmatively. For 
instance, in their study examining racial differences in response to ART for HIV-infection, 
Ribuardo et al. (2013) found that blacks had a 40% virologic failure compared to whites. In other 
words, HIV therapy worked differently in blacks than it did in whites. Racial differences in 
response to medication have also been found in the treatment of other health conditions. For 
instance, in a study on hypertension in patients with coronary artery disease, Steinberg (2013) 
found that many of the black patients required more hypertension medication at higher doses to 
achieve the desired goal. On the other hand, these goals were achieved at much lower doses 
among Hispanic and white patients. Literature on pharmacological genetics has also uncovered 
significant differences among racial and ethnic groups in the metabolism, clinical effectiveness, 
and side-effect profiles of many drugs (Burroughs, 2002; Wood, 2001). Based on this literature, 
it is reasonable to conclude that, among other possible reasons, the black-white differences in the 
risk for CVD observed in our study is because HIV therapy has more negative CVD-related 
outcomes among blacks than in whites. If true, this would highlight the need to apply these 
findings to HIV/AIDS treatment and for HIV/AIDS practitioners to develop and follow treatment 
protocols that consider individual risk factor profiles.  
Limitations 
Our study had three main limitations. First, since our review only included studies that 
were identified through MEDLINE, it is possible that if our study had included other relevant 
studies in abstract-format only and others that may have been indexed in other databases it may 
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have led to a different conclusion than the one we made in our study. Limiting our review to full-
text studies indexed in MEDLINE was in an attempt to replicate the previous review by 
Oramasionwu et al. (2012). Future reviews could overcome this limitation by including relevant 
studies that are unpublished, in abstract-format only, and in indexed in additional databases. 
Second, by limiting our review to studies that only examined U.S. populations, our findings 
cannot be broadly generalized. A much broader generalization can be achieved if future studies 
can examine global data. Finally, our study did not compare racial disparities in CVD among the 
HIV-infected blacks and non-Hispanic whites to the overall disparities of CVD in the general 
population (i.e. HIV-uninfected people). While our review has concluded that there is a black-
white disparity in the risk for CVD among people with HIV/AIDS, there is a possibility that the 
detected disparity may be explained by existing disparities in the general population and that the 
disparity we detected may be different (either smaller or larger) than existing disparities. The 
results of our review do not provide a basis for determining this one way or another since our 
review was limited by studies that did not separate their study participants by HIV-status. This 
provides a new direction for future research in this area. 
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